Comparison of percutaneous coronary intervention outcomes in diabetic patients with non-ST-elevation myocardial infarction having multivessel disease
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251628Keywords:
Non-STEMI, Multivessel PCI, Diabetes mellitus, MACCE, Revascularization strategyAbstract
Background: Diabetic patients with non-ST-elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (MVD) present unique challenges in revascularization strategy selection. This study compares the clinical outcomes of multivessel (MVR) versus single-vessel revascularization (SVR) using percutaneous coronary intervention (PCI) in such patients.
Methods: A prospective observational study was conducted at a tertiary center in Bangladesh including 110 diabetic NSTEMI patients with angiographically confirmed MVD. Patients underwent either MVR (n=58) or SVR (n=52). Outcomes assessed over a 6-month follow-up included major adverse cardiovascular and cerebrovascular events (MACCE), left ventricular ejection fraction (LVEF), functional capacity (METS), and survival.
Results: Baseline characteristics were comparable between groups. The MVR group had significantly more stents (2.36±0.49 vs. 1.17±0.38; p<0.01) and longer stent length (58.76±10.22 mm vs. 33.46±10.93 mm; p<0.01). MACCE was significantly lower in the MVR group (6.89% vs. 30.77%; p=0.001), with reduced myocardial infarction and revascularization rates. Both groups showed significant improvement in LVEF and METS post-PCI, with no significant intergroup difference. Kaplan–Meier analysis revealed superior event-free survival in the MVR group.
Conclusions: Multivessel PCI offers superior clinical outcomes and event-free survival in diabetic NSTEMI patients with MVD, without increasing periprocedural risks. Individualized risk-benefit assessment remains essential.
Metrics
References
Hung Y, Xuan H, Yiu K. Complete revascularisation versus culprit lesion only PCI in patients with non-ST-elevation myocardial infarction and multivessel disease. European Heart J. 2024;45(1):ehae666.1694. DOI: https://doi.org/10.1093/eurheartj/ehae666.1694
Akber S, Khan A, Khan F. Primary PCI For Multivessel Disease: Exploring the Optimal Strategy for Coronary Revascularization. Biological Clin Sci Res J. 2024;2024(1):1219. DOI: https://doi.org/10.54112/bcsrj.v2024i1.1219
Di Gioia G, Flores NS, Franco D, Colaiori I, Sonck J, Bartunek J, et al. Coronary artery bypass grafting vs. FFR-guided PCI in diabetic patients with multivessel disease. Circ Cardiovasc Interv. 2020;13(10):e009157. DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.120.009157
Wang C, Jiachun L, Zhang J, Yuecheng H, Chuyi H, Rongdi X, et al. Culprit vessel vs. immediate multivessel vs. out-of-hospital staged intervention for patients with non-ST-segment elevation myocardial infarction and multivessel disease. Front Cardiovascular Med. 2022;9:1033475. DOI: https://doi.org/10.3389/fcvm.2022.1033475
Omer MA, Brilakis ES, Kennedy KF, Alkhouli M, Elgendy IY, Chan PS, et al. Multivessel versus culprit-vessel percutaneous coronary intervention in patients with non-ST-segment elevation myocardial infarction and cardiogenic shock. Cardiovascular Intervent. 2021;14(10):1067-78. DOI: https://doi.org/10.1016/j.jcin.2021.02.021
Islam SMS, Purnat TD, Phuong NTA, Mwingira U, Schacht K, Fröschl G. Non-communicable diseases (NCDs) in developing countries: a symposium report. Global Health. 2014;10:81. DOI: https://doi.org/10.1186/s12992-014-0081-9
Onuma Y, Takashi M, Chrysafios G, Neville K, Garcia-Garcia HM, Daemen J, et al. Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes. Euro Intervention. 2013;9(8):916-22. DOI: https://doi.org/10.4244/EIJV9I8A154
Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J. 2008;155(1):140-6. DOI: https://doi.org/10.1016/j.ahj.2007.09.007
Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G, Lansky AJ, et al. The Future Revascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am Heart J. 2012;164(4):591-9. DOI: https://doi.org/10.1016/j.ahj.2012.06.012
Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2004;109(4):476-80. DOI: https://doi.org/10.1161/01.CIR.0000109693.64957.20
Hillegass W. Multivessel disease in diabetics: Does DES level the field? Catheterization Cardiovascular Interventions. 2009;73(7):881-82. DOI: https://doi.org/10.1002/ccd.22102
Rathod KS, Sudheer K, Jain AK, Zoe A, Pitt L, Roby R, et al. Complete versus culprit-only lesion intervention in patients with acute coronary syndromes. J Am College Cardiol. 2018;72(17):1989-99. DOI: https://doi.org/10.1016/j.jacc.2018.07.089
Nathan S, Attanasio S, Amin A, Kumar A, Gupta A, Kelly RF. 11 long-term outcomes of single versus multivessel stenting in a public health system patient population with uniform bare metal stent selection, adjunctive glycoprotein iib/iiia inhibition and long-term dual antipla℡et therapy. Catheterization Cardiovascular Interventions. 2005;69(6):S1-S96. DOI: https://doi.org/10.1177/1081558905053001556
Kasper K, Ahtarovski KA, Nepper-Christensen L, Ekström K, Ghotbi AA, Schoos M, et al. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. Cardiovascular Interventions. 2019;12(8):721-30. DOI: https://doi.org/10.1016/j.jcin.2019.01.248
Calvo M, Guzman J, Perez P, Ortega LG, Mendieta G, Lorenzatti D, et al. Complete revascularization of non-culprit lesions in stemi is associated with improved myocardial salvage and reduced microvascular obstruction: a cardiac magnetic resonance study. European Heart J. 2020;2:ehaa946-1769. DOI: https://doi.org/10.1093/ehjci/ehaa946.1769
Tiksnadi BB, Marita I, Najiyah HH, Astuti AW, Sastradimaja SB. Predictors of functional capacity improvement after cardiac rehabilitation following coronary artery revascularization. Euro J Prevent Cardiol. 2024;31(1):zwae175.209. DOI: https://doi.org/10.1093/eurjpc/zwae175.209
Kapur A, Qureshi AC, Gallagher S, Finlay M, Malik IS, Mayet J, et al. Myocardial function may improve equally in diabetic patients following both multivessel percutaneous coronary intervention and coronary artery bypass grafting: results from a CARDia trial substudy. Eur J Echocardiography. 2011;12(12):904-9. DOI: https://doi.org/10.1093/ejechocard/jer149
Jia S, Liu Y, Yao Y, Yang YJ, Gao RL, Xu B, Yuan JQ. P4596 Long-term outcomes of culprit lesion only versus multi-vessel one-stage intervention in non-ST elevation acute coronary syndrome patients undergoing percutaneous coronary intervention. Eur Heart J. 2019;40(1):ehz745-0980. DOI: https://doi.org/10.1093/eurheartj/ehz745.0980
Downloads
Published
How to Cite
Issue
Section
